Skip to main content
. Author manuscript; available in PMC: 2024 Aug 24.
Published in final edited form as: J Med Chem. 2023 Aug 8;66(16):11250–11270. doi: 10.1021/acs.jmedchem.3c00671

Scheme 1.

Scheme 1.

Reagents and Conditions for the Synthesis of Designed BRD7 Inhibitorsa

a(a) NaH, DMF (anhydrous), CH3I at 0 °C warm to rt, 16 h; (b) Pd(dppf)Cl2, Cs2CO3, DMF (anhydrous), reflux, 16 h; (c) Pd(dppf)Cl2, Cs2CO3,, 1,4-dioxane (anhydrous), reflux, 48−72 h; (d) aryl aldehyde in THF at 0 °C, Grignard reagent added over 10 min, then quenched; (e) pyridinium dichromate, DCM.